Logo.jpg
ProPhase Labs to Present at the Planet MicroCap Showcase: VIRTUAL 2022 on Wednesday, December 7, 2022
November 30, 2022 08:00 ET | ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 30, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced that it will be...
Logo.jpg
ProPhase Labs to Present at Investor Summit Group’s Q4 Conference
November 07, 2022 19:12 ET | ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 07, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced it will be...
Logo.jpg
ProPhase Labs Announces Collaboration with G42 Healthcare
October 19, 2022 08:00 ET | ProPhase Labs, Inc.
Companies target emerging markets across the globe and joint venture opportunitiesProPhase and G42 Healthcare to explore creation of advanced genomic sequencing facility in the USCompanies enter...
Logo.jpg
Nebula Genomics Strengthens Advisory Board with Appointment of Russ Altman, M.D., Ph.D.
October 17, 2022 08:00 ET | ProPhase Labs, Inc.
GARDEN CITY, NY, Oct. 17, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth-oriented and diversified diagnostics, genomics and biotech company, today announced that its wholly...
Logo.png
Earth Science Tech, Inc. (ETST) Becomes Current with the SEC and Shares Updates to the Market
October 05, 2021 08:00 ET | Earth Science Tech, Inc.
DORAL, Florida, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), an innovative biotech company nutraceutical and pharmaceutical fields, and medical...
ritter.jpg
Ritter Pharmaceuticals, Inc. Urges Stockholders to Vote Now on Proposed Merger with Biotech Company, Qualigen Inc.
April 28, 2020 07:30 ET | Ritter Pharmaceuticals, Inc.
The merger CANNOT be consummated without the approval of EACH of the proposals being voted on at the Special Meeting, including approval of a reverse stock split. LOS ANGELES, April 28, 2020 ...
Rheostat Therapeutics.jpg
Rheostat Therapeutics Announces $23 Million Series A Financing; To Develop Potential Treatments for Neurodegenerative Diseases
November 26, 2018 09:00 ET | Rheostat Therapeutics
CAMBRIDGE, Mass., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Rheostat Therapeutics, a biotech company focused on the discovery of novel treatments for neurodegeneration, cognition and rare diseases, today...
Cannabis Leaf (PCFP) Apotheca Biosciences Provides Corporate Update Solving Opioid Addiction is Our First Priority
May 23, 2018 09:00 ET | Cannabis Leaf, Inc./Apotheca Biosciences
Seattle, WA , May 23, 2018 (GLOBE NEWSWIRE) -- Cannabis Leaf (OTC:PCFP) Apotheca Biosciences Provides Corporate Update – Solving Opioid Addiction is Our First Priority. Apotheca Biosciences is a...